Atjaunināt sīkdatņu piekrišanu

E-grāmata: From Melanocytes to Melanoma: The Progression to Malignancy

  • Formāts: PDF+DRM
  • Izdošanas datums: 05-Nov-2007
  • Izdevniecība: Humana Press Inc.
  • Valoda: eng
  • ISBN-13: 9781592599943
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 118,37 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: PDF+DRM
  • Izdošanas datums: 05-Nov-2007
  • Izdevniecība: Humana Press Inc.
  • Valoda: eng
  • ISBN-13: 9781592599943
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Melanoma, the deadliest form of skin cancer, offers a good general model for studying the progression of normal cells into malignant ones toward more effective diagnosis and treatment. Hearing (National Cancer Institute, National Institutes of Health, Bethesda, Maryland) and Leong (surgery, U. of California School of Medicine, San Francisco) introduce 37 chapters by international researchers that provide an up-to-date review of what is known about the molecular mechanisms involved in this transformation, recent advances in understanding the basic biology of these cells and the further progression of primary melanoma into invasive melanomas, and the clinical implications. The editors also note the populations that are most at risk. The text is augmented by four color plates. Annotation ©2006 Book News, Inc., Portland, OR (booknews.com)

Leading researchers and clinicians join forces to explain how malignant melanoma develops from its benign precursor cell type. The authors focus on the molecular mechanisms involved in melanogenesis, in the malignant transformation of melanocytes, and in the further progression of primary melanomas into invasive and metastatic melanomas. They also review recent advances in our understanding of the basic biology of melanocytes and the development, migration, and differentiation of melanoblasts into melanocytes. The book provides an up-to-date understanding of the progressive mechanisms of oncological development in malignant melanoma, a likely model of malignant progress for other types of cancer, and the ongoing development of novel therapeutics.

This important volume provides an understanding of the molecular mechanisms involved in melanogenesis and in malignant transformation of melanocytes. By studying the molecular signals involved in these processes, model systems can be developed that trace the molecular mechanisms involved in the malignant transformation of melanocytes to malignant melanoma.

Recenzijas

From the reviews:



"...this compendium of current thinking is recommended reading for anyone with an interest in pigmentation and cancer and a valuable resource for any library." -Melanoma Research



"This book, the first of its kind on melanoma, details the current state of our knowledge . should be viewed as an important resource for understanding the broad field of melanocyte and melanoma biology. Newcomers to the field will find this book extremely useful. This book captures the tremendous progress made in the field . It is a valuable resource for biologists and basic scientists as well as for pathologists; dermatologists, surgeons, and medical oncologists ." (Lynn M. Schuchter, The New England Journal of Medicine, March, 2007)



"...captures the tremendous progress made in the field...will help to propel the field to new successes...a valuable resource for biologists and basic scientists interested in the biology of pigment cells as well as for pathologists, dermatologists, surgeons, and medical oncologists interested in the diagnosis and treatment of melanoma." -New England Journal of Medicine



"The editors have compiled a highly prestigious group of authors, who are leaders in the field of melanocyte and melanoma research, to present a very comprehensive exposition of the current knowledge of melanocyte biology and melanoma. As a clinical researcher, I found it fascinating, yielding a tremendous appreciation for the meticulous and extensive work that has been done to date, some of which has and more of which will very likely provide leads to clinical interventions." (Janice P. Dutcher, Medical Oncology, Vol. 23 (3), 2006)



"An extremely detailed book on each of the various pathways, growth factors, and oncogenes affecting the melanocyte. This is a comprehensive review and physicians such as dermatologists, pathologists, and oncologists will find it helpful. It is very thorough in itspresentation of cellular events . This book will serve primarily as a reference for basic scientists and biologists. Physician scientists will also use the book. Clinicians may find the book highly detailed, with more information then they require." (Mary C. Martini, Doodys Review Service, July, 2006)

Papildus informācija

Important and Authoritative Text on the Diagnosis and Treatment of Melanoma
Preface v
Acknowledgment vii
Contributors xiii
List of Color Plates
xvii
Part I. Melanocyte Development and Function
The Origin and Development of Neural Crest-Derived Melanocytes
3(24)
Debra L. Silver
William J. Pavan
MITF: A Matter of Life and Death for Developing Melanocytes
27(24)
Heinz Arnheiter
Ling Hou
Minh-Thanh T. Nguyen
Keren Bismuth
Tamas Csermely
Hideki Murakami
Susan Skuntz
Wen Fang Liu
Kapil Bharti
MITF: Critical Regulator of the Melanocyte Lineage
51(20)
Erez Feige
Laura L. Poling
David E. Fisher
Melanocytes and the Transcription Factor Sox 10
71(10)
Michael Wegner
Human Cutaneous Pigmentation: A Collaborative Act in the Skin, Directed by Paracrine, Autocrine, and Endocrine Factors and the Environment
81(20)
Zalfa A. Abdel-Malek
Ana Luisa Kadekaro
Melanocyte Distribution and Function in Human Skin: Effects of Ultraviolet Radiation
101(18)
Yuji Yamaguchi
Vincent J. Hearing
Part II. Melanocyte Transformation and Progression to Melanoma
Altered Signal Transduction in Melanoma
119(30)
Pablo Lopez Bergami
Anindita Bhoumik
Ze'ev Ronai
BRN2 in Melanocytic Cell Development, Differentiation, and Transformation
149(20)
Anthony L. Cook
Glen M. Boyle
J. Helen Leonard
Peter G. Parsons
Richard A. Sturm
The Dynamic Roles of Cell-Surface Receptors in Melanoma Development
169(14)
Dong Fang
Meenhard Herlyn
Familial Melanoma Genes, Melanocyte Immortalization, and Melanoma Initiation
183(14)
Dorothy C. Bennett
Genetic Progression From Melanocyte to Malignant Melanoma
197(14)
Boris C. Bastian
The Multiple Roles of the Oncogenic Protein SKI in Human Malignant Melanoma
211(12)
Dahu Chen
Qiushi Lin
I. Saira Mian
Jon Reed
Estela E. Medrano
RB/E2F Regulation and Dual Activity in the Melanocytic System
223(24)
Ruth Halaban
Melanoma Development and Pigment Cell Transformation
247(18)
Claudia Wellbrock
The Biology and Genetics of Melanoma
265(26)
Norman E. Sharpless
Lynda Chin
The Biology of Xeroderma Pigmentosum: Insights Into the Role of Ultraviolet Light in the Development of Melanoma
291(20)
James E. Cleaver
Divergent Pathways to Cutaneous Melanoma
311(18)
David C. Whiteman
Adele C. Green
Pigmentation, DNA Repair, and Candidate Genes: The Risk of Cutaneous Malignant Melanoma in a Mediterranean Population
329(18)
Maria Teresa Landi
Low-Penetrance Genotypes, Pigmentation Phenotypes, and Melanoma Etiology
347(18)
Peter A. Kanetsky
Timothy R. Rebbeck
The Biology of Melanoma Progression: From Melanocyte to Metastatic Seed
365(34)
A. Neil Crowson
Cynthia Magro
Martin C. Mihm, Jr.
Optical Imaging Analysis of Atypical Nevi and Melanoma
399(10)
Amanda Pfaff Smith
Dorothea Becker
Proteomics Analysis of Melanoma Cell Lines and Cultured Melanocytes
409(20)
Katheryn A. Resing
Natalie G. Ahn
Part III. Primary Invasive Melanoma to Metastatic Melanoma
Paradigm of Metastasis for Malignant Melanoma
429(12)
Stanley P. L. Leong
Repair of UV-Induced DNA Damage and Melanoma Risk
441(14)
Qingyi Wei
High-Risk Factors for Melanoma Metastasis
455(20)
Neil A. Accortt
Seng-jaw Soong
Role of Melanoma Inhibitory Activity in Early Development of Malignant Melanoma
475(14)
Anja-Katrin Bosserhoff
Role and Regulation of PAR-1 in Melanoma Progression
489(14)
Carmen Tellez
Menashe Bar-Eli
Molecular Mechanisms of Melanoma Metastasis
503(10)
Mohammed Kashani-Sabet
Overview of Tumor Progression in Melanoma
513(20)
David E. Elder
The Plasticity of Melanoma Cells and Associated Clinical Implications
533(18)
Mary J. C. Hendrix
Elisabeth A. Seftor
Angela R. Hess
Richard E. B. Seftor
The Clinical Use of Molecular Markers as Predictors of Disease Outcome and Response to Therapy in Malignant Melanoma
551(26)
Steve R. Martinez
Hiroya Takeuchi
Dave S. B. Hoon
The Role of DCT/TYRP2 in Resistance of Melanoma Cells to Drugs and Radiation
577(14)
Brian J. Pak
Yaacov Ben-David
How Melanoma Cells Evade Chemotherapy: Role of Transporter-Dependent and -Independent Resistance Mechanisms
591(14)
Kevin G. Chen
Michael M. Gottesman
Apoptosis in Melanoma: Approaches to Therapy
605(14)
Heike Rockmann
Dirk Schadendorf
Role of Melanoma-Associated Antigens
619(14)
Rishab K. Gupta
Ana M. McElrath-Garza
Donald L. Morton
Host Responses to Melanoma: Implications for Immunotherapy
633(18)
Julian A. Kim
Ernest Borden
Future Perspectives
651(2)
Vincent J. Hearing
Stanley P. L. Leong
Index 653